| Original language | English |
|---|---|
| Pages (from-to) | 75-76 |
| Number of pages | 2 |
| Journal | Rheumatology |
| Volume | 55 |
| Issue number | Suppl. 1 |
| DOIs | |
| Publication status | Published - 24 Apr 2016 |
| Event | Annual Meeting of the British-Society-for-Rheumatology, British-Health-Professionals-in-Rheumatology and the British-Society-for-Paediatric-and-Adolescent-Rheumatology (Rheumatology) - Glasgow Duration: 26 Apr 2016 → 28 Apr 2016 |
Bibliographical note
G.J.M. has received honoraria from Pfizer and research funding from AbbVie, Pfizer and UCB. G.T.J. has received research funding from AbbVie, Pfizer and UCB. All other authors have declared no conflicts of interest.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS